We are live on ! Find out more
EXAS icon

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

527 hedge funds and large institutions have $12.1B invested in Exact Sciences in 2019 Q4 according to their latest regulatory filings, with 125 funds opening new positions, 199 increasing their positions, 128 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more capital inflows, than outflows

Capital inflows: $2.5B | Capital outflows: $860M

98% more first-time investments, than exits

New positions opened: 125 | Existing positions closed: 63

86% more funds holding in top 10

Funds holding in top 10: 7 → 13 (+6)

55% more repeat investments, than reductions

Existing positions increased: 199 | Existing positions reduced: 128

11% more funds holding

Funds holding: 476 → 527 (+51)

0.64% more ownership

Funds ownership: 87.9% → 88.54% (+0.64%)

42% less call options, than puts

Call options by funds: $317M | Put options by funds: $545M

Holders
527
Holders Change
+51
Holders Change %
+10.71%
% of All Funds
10.35%
Holding in Top 10
13
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+85.71%
% of All Funds
0.26%
New
125
Increased
199
Reduced
128
Closed
63
Calls
$317​M
Puts
$545​M
Net Calls
-⁠$227​M
Net Calls Change
+$68.8​M

EXAS Hedge Fund Activity: Q4 2019 in Review

527 of the 5,090 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q4 2019, worth a combined $12.1B — up 17% from $10.3B a quarter earlier.

Buyers outnumbered sellers: 125 funds opened new EXAS positions and 63 closed out — a net gain of 62 holders — while 199 added to existing stakes and 128 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $622M. The largest seller was Wellington Management Group, cutting an estimated $167M.

  • 527 institutional investors held Exact Sciences (EXAS) as of Q4 2019, up from 476 in Q3 2019.
  • Funds reported $12.1B of Exact Sciences stock for Q4 2019, up 17% quarter-over-quarter.
  • 125 funds opened new Exact Sciences positions in Q4 2019 and 63 closed out, a net change of +62 holders.
  • The largest Exact Sciences buyer in Q4 2019 was T. Rowe Price Associates, an estimated $622M added.
  • The largest Exact Sciences seller in Q4 2019 was Wellington Management Group, an estimated $167M sold.

Based on aggregated 13F filings for Q4 2019.